{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:10:17Z","timestamp":1793859017411,"version":"4.6.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1015,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41379-019-0393-7","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T14:10:22Z","timestamp":1572531022000},"page":"676-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey"],"prefix":"10.1016","volume":"33","author":[{"given":"Maria","family":"Westerhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Osecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9491-3609","authenticated-orcid":false,"given":"Rupert","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-019-0393-7_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-019-0393-7_bib2","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-019-0393-7_bib3","doi-asserted-by":"crossref","unstructured":"Ychou M, Boige V, Pignon J-P, Conroy T, Bouch\u00e9 O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: a FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29:1715\u201321.","DOI":"10.1200\/JCO.2010.33.0597"},{"key":"10.1038\/s41379-019-0393-7_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","article-title":"Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial","volume":"13","author":"R\u00f6del","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib5","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cncr.20916","article-title":"Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation","volume":"103","author":"Chirieac","year":"2005","journal-title":"Cancer."},{"key":"10.1038\/s41379-019-0393-7_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1038\/s41379-019-0393-7_bib8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"99","author":"Martin","year":"2012","journal-title":"Br J Surg"},{"key":"10.1038\/s41379-019-0393-7_bib9","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1200\/JCO.2011.34.9068","article-title":"Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience","volume":"29","author":"Patel","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1874375700903020091","article-title":"Histopathology of colorectal cancer after neoadjuvant chemoradiation therapy","volume":"3","author":"Damjanov","year":"2009","journal-title":"Open Pathol J."},{"key":"10.1038\/s41379-019-0393-7_bib11","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.2009.123","article-title":"Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas","volume":"22","author":"Langer","year":"2009","journal-title":"Mod Pathol."},{"key":"10.1038\/s41379-019-0393-7_bib12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker","year":"2003","journal-title":"Cancer."},{"key":"10.1038\/s41379-019-0393-7_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1309\/CCR3QN4874YJDJJ7","article-title":"Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues","volume":"129","author":"Chang","year":"2008","journal-title":"Am J Clin Path"},{"key":"10.1038\/s41379-019-0393-7_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy","volume":"12","author":"Dworak","year":"1997","journal-title":"Int J Colorectal Dis"},{"key":"10.1038\/s41379-019-0393-7_bib15","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"10.1038\/s41379-019-0393-7_bib16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/01.sla.0000186170.38348.7b","article-title":"Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification","volume":"242","author":"Schneider","year":"2005","journal-title":"Ann Surg."},{"key":"10.1038\/s41379-019-0393-7_bib17","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","article-title":"Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer","volume":"23","author":"R\u00f6del","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/01.sla.0000161983.82345.85","article-title":"Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)","volume":"241","author":"Swisher","year":"2005","journal-title":"Ann Surg."},{"key":"10.1038\/s41379-019-0393-7_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1200\/JCO.2006.08.0101","article-title":"American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma","volume":"25","author":"Rizk","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00428-017-2232-x","article-title":"Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy","volume":"472","author":"Langer","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1038\/s41379-019-0393-7_bib21","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1200\/JCO.2015.65.7692","article-title":"Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial","volume":"34","author":"Smyth","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1470-2045(17)30043-8","article-title":"Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial","volume":"18","author":"Cunningham","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1038\/s41379-019-0393-7_bib23","doi-asserted-by":"crossref","unstructured":"Fokas E, Strobel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer GG, et al. Tumor regression grading after preoperative chemoradiotherapy as a prognostic factor and individual-level surrogate for disease-free survival in rectal cancer. J Natl Cancer Inst. 2017;109:djx095.","DOI":"10.1093\/jnci\/djx095"},{"key":"10.1038\/s41379-019-0393-7_bib24","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/bjs.10627","article-title":"Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma","volume":"104","author":"Noble","year":"2017","journal-title":"Br J Surg"},{"key":"10.1038\/s41379-019-0393-7_bib25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1470-2045(17)30447-3","article-title":"Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial","volume":"18","author":"Alderson","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1038\/s41379-019-0393-7_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/gut.2008.155861","article-title":"Biomarkers of response to therapy in oesophago-gastric cancer","volume":"58","author":"Fareed","year":"2009","journal-title":"Gut."},{"key":"10.1038\/s41379-019-0393-7_bib27","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"Al-Batran","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1038\/s41379-019-0393-7_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12876-017-0598-5","article-title":"Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China","volume":"17","author":"Zhu","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"10.1038\/s41379-019-0393-7_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00428-012-1193-3","article-title":"A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation","volume":"460","author":"Chetty","year":"2012","journal-title":"Virchows Arch."},{"key":"10.1038\/s41379-019-0393-7_bib30","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.humpath.2012.01.020","article-title":"International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems","volume":"43","author":"Chetty","year":"2012","journal-title":"Hum Pathol."},{"key":"10.1038\/s41379-019-0393-7_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","article-title":"Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"47","author":"Ryan","year":"2005","journal-title":"Histopathology."},{"key":"10.1038\/s41379-019-0393-7_bib32","unstructured":"Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8th ed. Springer International Publishing, Chicago; 2017."},{"key":"10.1038\/s41379-019-0393-7_bib33","doi-asserted-by":"crossref","unstructured":"Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th ed. part I. Esophagus. 2017;14:1\u201336.","DOI":"10.1007\/s10388-016-0551-7"},{"key":"10.1038\/s41379-019-0393-7_bib34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2559.2009.03292.x","article-title":"Rectal cancer staging post neoadjuvant therapy-how should the changes be assessed?","volume":"54","author":"Bateman","year":"2009","journal-title":"Histopathology."},{"key":"10.1038\/s41379-019-0393-7_bib35","unstructured":"Osecky M. Development of an international online survey to investigate the usage of tumor regression grading systems for gastrointestinal cancers after neoadjuvant therapy [Master Thesis]. Bern: University of Bern; 2019."},{"key":"10.1038\/s41379-019-0393-7_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/COC.0b013e318172d5c5","article-title":"Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial","volume":"31","author":"Le Scodan","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archsurg.1992.01420110083017","article-title":"Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas","volume":"127","author":"Evans","year":"1992","journal-title":"Arch Surg."},{"key":"10.1038\/s41379-019-0393-7_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/annonc\/mdl386","article-title":"Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery","volume":"18","author":"Rubbia-Brandt","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib39","unstructured":"College of the American Pathologists. 2017 [Available from: https:\/\/documents.cap.org\/protocols\/cp-esophagus-17protocol-4000.pdf."},{"key":"10.1038\/s41379-019-0393-7_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.pas.0000213312.36306.cc","article-title":"Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome","volume":"31","author":"Wu","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0393-7_bib41","doi-asserted-by":"crossref","unstructured":"Trakarnsanga A, Gonen M, Shia J, Nash GM, Temple LK, Guillem JG, et al. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst. 2014;106:dju248.","DOI":"10.1093\/jnci\/dju248"},{"key":"10.1038\/s41379-019-0393-7_bib42","first-page":"8","article-title":"Assessment of histopathological response in gastric and gastro-oesophageal junction adenocarcinoma following neoadjuvant chemotherapy: which scoring system to use? ISRN","volume":"2012","author":"Mirza","year":"2012","journal-title":"Pathology."},{"key":"10.1038\/s41379-019-0393-7_bib43","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/PAS.0000000000000255","article-title":"Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches","volume":"38","author":"Karamitopoulou","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0393-7_bib44","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.ejso.2017.03.001","article-title":"Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: a meta-analysis of 17 published studies","volume":"43","author":"Tomasello","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib45","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1245\/s10434-013-3410-y","article-title":"A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy","volume":"21","author":"Langer","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib46","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/SLA.0b013e3182a196f4","article-title":"The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma","volume":"258","author":"Francis","year":"2013","journal-title":"Ann Surg."},{"key":"10.1038\/s41379-019-0393-7_bib47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/SLA.0b013e318216f449","article-title":"Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases","volume":"253","author":"Becker","year":"2011","journal-title":"Ann Surg."},{"key":"10.1038\/s41379-019-0393-7_bib48","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/SLA.0b013e3182a66588","article-title":"Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard","volume":"258","author":"Donohoe","year":"2013","journal-title":"Ann Surg."},{"key":"10.1038\/s41379-019-0393-7_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cncr.23516","article-title":"Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation","volume":"113","author":"Quah","year":"2008","journal-title":"Cancer."},{"key":"10.1038\/s41379-019-0393-7_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/DCR.0000000000000266","article-title":"American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer","volume":"58","author":"Mace","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"10.1038\/s41379-019-0393-7_bib51","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00268-011-1409-8","article-title":"Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy","volume":"36","author":"Huebner","year":"2012","journal-title":"World J Surg"},{"key":"10.1038\/s41379-019-0393-7_bib52","doi-asserted-by":"crossref","first-page":"e2257","DOI":"10.1097\/MD.0000000000002257","article-title":"Is pathologic near-total regression an appropriate indicator of a good response to preoperative chemoradiotherapy based on oncologic outcome of disease?","volume":"94","author":"Kim","year":"2015","journal-title":"Medicine (Baltim)."},{"key":"10.1038\/s41379-019-0393-7_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2014.05.010","article-title":"Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome","volume":"112","author":"Swellengrebel","year":"2014","journal-title":"Radiother Oncol."},{"key":"10.1038\/s41379-019-0393-7_bib54","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/jso.23181","article-title":"Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection","volume":"106","author":"Lim","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1038\/s41379-019-0393-7_bib55","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10120-014-0401-z","article-title":"Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A)","volume":"18","author":"Nakamura","year":"2015","journal-title":"Gastric Cancer."},{"key":"10.1038\/s41379-019-0393-7_bib56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2559.2009.03404.x","article-title":"Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy","volume":"55","author":"Fareed","year":"2009","journal-title":"Histopathology."},{"key":"10.1038\/s41379-019-0393-7_bib57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00428-015-1901-x","article-title":"Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma","volume":"468","author":"Fern\u00e1ndez-Ace\u00f1ero","year":"2016","journal-title":"Virchows Arch."},{"key":"10.1038\/s41379-019-0393-7_bib58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/his.12432","article-title":"Pathological prognostic factors in locally advanced rectal carcinoma after neoadjuvant radiochemotherapy: analysis of 113 cases","volume":"65","author":"Sannier","year":"2014","journal-title":"Histopathology."},{"key":"10.1038\/s41379-019-0393-7_bib59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/j.semtcvs.2016.04.003","article-title":"Prognostic relevance of lymph node regression after neoadjuvant chemoradiation for esophageal cancer","volume":"28","author":"Philippron","year":"2016","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1038\/s41379-019-0393-7_bib60","doi-asserted-by":"crossref","first-page":"998","DOI":"10.4143\/crt.2015.254","article-title":"What is the ideal tumor regression grading system in rectal cancer patients after preoperative chemoradiotherapy?","volume":"48","author":"Kim","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1038\/s41379-019-0393-7_bib61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/modpathol.2017.87","article-title":"Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy","volume":"31","author":"Pai","year":"2017","journal-title":"Mod Pathol."},{"key":"10.1038\/s41379-019-0393-7_bib62","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pan.2018.04.010","article-title":"Pathology assessment of pancreatic cancer following neoadjuvant treatment: time to move on","volume":"18","author":"Verbeke","year":"2018","journal-title":"Pancreatology."},{"key":"10.1038\/s41379-019-0393-7_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.humpath.2018.08.028","article-title":"Histopathologic tumor regression grading in patients with gastric carcinoma submitted to neoadjuvant treatment: results of a Delphi survey","volume":"84","author":"Tsekrekos","year":"2019","journal-title":"Hum Pathol."},{"key":"10.1038\/s41379-019-0393-7_bib64","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/SLA.0000000000000280","article-title":"Reply to letter: \u201cTumor regression after neoadjuvant chemotherapy in gastric carcinoma: are there really so few responders?\u201d","volume":"259","author":"Langer","year":"2014","journal-title":"Ann Surg."},{"key":"10.1038\/s41379-019-0393-7_bib65","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejca.2016.02.020","article-title":"Immunotherapy in gastrointestinal cancer: recent results, current studies and future perspectives","volume":"59","author":"Moehler","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-019-0393-7_bib66","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/PAS.0000000000000672","article-title":"Pathologic response of HER2-positive gastric cancer to trastuzumab-based chemotherapy","volume":"40","author":"Urabe","year":"2016","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0393-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0393-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222008936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222008936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0393-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:43:22Z","timestamp":1760229802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222008936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0893395222008936"],"URL":"https:\/\/doi.org\/10.1038\/s41379-019-0393-7","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-019-0393-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}